PET and MRI of the thalamus in never-medicated patients with schizophrenia.

OBJECTIVE This study reports the first paired measurements of glucose metabolism and size of thalamic regions in never-medicated schizophrenic patients using coregistered magnetic resonance imaging (MRI) templates. METHOD Positron emission tomography with [18F]fluorodeoxyglucose and matching MRI scans were obtained in 20 never-medicated patients with schizophrenia and 15 normal volunteers. Methods for thalamic edge finding, statistical testing of shape differences with chi-square maps, and MRI localization of major thalamic subregions were developed. RESULTS Patients with schizophrenia showed a diminished metabolic rate in the right thalamus, with a loss of the normal pattern of right greater than left asymmetry. Division into anterior/posterior segments revealed that the left anterior and right posterior showed the decrease. Differences were greater for metabolism in the weighted thalamic area (ratexarea) than for rate per unit area, a finding consistent with reported greater decreases in total neuron number than of neuron density in the thalami of schizophrenic patients. The area of the thalamus was smaller in the patients than in the volunteers, and this difference was greatest in the left anterior region. CONCLUSIONS The reduced thalamic activity observed in this study lends further support to the concept of deficits in sensory filtering in schizophrenia.

[1]  A. Mcghie,et al.  Disorders of attention and perception in early schizophrenia. , 1961, The British journal of medical psychology.

[2]  Barbara A. Cornblatt,et al.  The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients , 1989, Psychiatry Research.

[3]  B. Pakkenberg,et al.  Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. , 1990, Archives of general psychiatry.

[4]  N C Andreasen,et al.  Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. , 1992, Archives of general psychiatry.

[5]  S. Potkin,et al.  Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. , 1993, American Journal of Psychiatry.

[6]  J. M. Van Buren,et al.  Variations and Connections of the Human Thalamus , 1972 .

[7]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[8]  J. Ehrhardt,et al.  Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. , 1990, Archives of general psychiatry.

[9]  E. Metter,et al.  Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. , 1986, The American journal of psychiatry.

[10]  E. G. Jones,et al.  Distribution of tachykinin- and enkephalin-immunoreactive fibers in the human thalamus , 1989, Brain Research Reviews.

[11]  M. Buchsbaum,et al.  Stimulus Intensity Control and the Cortical Evoked Response , 1968, Psychosomatic medicine.

[12]  R Parasuraman,et al.  Visual sustained attention: image degradation produces rapid sensitivity decrement over time. , 1983, Science.

[13]  D. Stuss,et al.  The Frontal Lobes , 1986 .

[14]  M. Posner,et al.  Deficits in human visual spatial attention following thalamic lesions. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Alavi,et al.  Positron emission tomography and subcortical glucose metabolism in schizophrenia , 1988, Psychiatry Research.

[16]  S. Stone-Elander,et al.  Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates , 1987, Acta psychiatrica Scandinavica.

[17]  J. Ehrhardt,et al.  Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. , 1994, Science.

[18]  W T Carpenter,et al.  Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. , 1992, Archives of general psychiatry.

[19]  John K. Wing,et al.  Measurement and Classification of Psychiatric Symptoms: An Instruction Manual for the PSE and Catego Program , 1974 .

[20]  J. Lieberman,et al.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. , 1994, The American journal of psychiatry.

[21]  M S Buchsbaum,et al.  Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[22]  N. Risch,et al.  The continuous performance test, identical pairs version (CPT-IP): I. new findings about sustained attention in normal families , 1988, Psychiatry Research.

[23]  M S Buchsbaum,et al.  The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. , 1990, Schizophrenia bulletin.

[24]  M S Buchsbaum,et al.  Glucose Metabolic Rate in Normals and Schizophrenics During the Continuous Performance Test Assessed by Positron Emission Tomography , 1990, British Journal of Psychiatry.

[25]  D L Braff,et al.  Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. , 1991, Archives of general psychiatry.

[26]  R. Liberman,et al.  Symptom monitoring in the rehabilitation of schizophrenic patients. , 1986, Schizophrenia bulletin.

[27]  L. DeLisi,et al.  Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients , 1987, Biological Psychiatry.

[28]  P. Venables,et al.  INPUT DYSFUNCTION IN SCHIZOPHRENIA. , 1964, Progress in experimental personality research.

[29]  Nancy C. Andreasen,et al.  Problems with ratio and proportion measures of imaged cerebral structures , 1991, Psychiatry Research: Neuroimaging.

[30]  H. Herzog,et al.  PET and neuropsychology in thalamic infarction: Evidence for associated cortical dysfunction , 1989, Psychiatry Research.

[31]  A Carlsson,et al.  Schizophrenia: a subcortical neurotransmitter imbalance syndrome? , 1990, Schizophrenia bulletin.

[32]  S. Potkin,et al.  Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. , 1992, Archives of general psychiatry.

[33]  J C Mazziotta,et al.  Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.

[34]  D. LaBerge,et al.  Positron emission tomographic measurements of pulvinar activity during an attention task , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  J. Baron,et al.  Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man. , 1986, Brain : a journal of neurology.